Cargando…
MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction
OBJECTIVE: This study is aimed at exploring the underlying molecular mechanisms of ST-segment elevation myocardial infarction (STEMI) and provides potential clinical prognostic biomarkers for STEMI. METHODS: The GSE60993 dataset was downloaded from the GEO database, and the differentially expressed...
Autores principales: | Xiao, Shengjue, Xue, Tongneng, Pan, Qinyuan, Hu, Yue, Wu, Qi, Liu, Qiaozhi, Wang, Xiaotong, Liu, Ailin, Liu, Jie, Zhu, Hong, Zhou, Yufei, Pan, Defeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561321/ https://www.ncbi.nlm.nih.gov/pubmed/34786024 http://dx.doi.org/10.1155/2021/2923441 |
Ejemplares similares
-
Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
por: Pan, Defeng, et al.
Publicado: (2021) -
Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Xiao, Shengjue, et al.
Publicado: (2021) -
Novel grading system for ischemia‒reperfusion injury manifestations in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Wang, Xiaotong, et al.
Publicado: (2022) -
Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis
por: Xiao, Shengjue, et al.
Publicado: (2021) -
Diagnostic value of parameters derived from planar MUGA for detecting HFpEF in coronary artery disease patients
por: Liu, Qiaozhi, et al.
Publicado: (2023)